Retrospective Study of 23 Cases of Psoriasis Association with HIV Infection Observed in the Department of Dermatology-STD in the University Hospital of Donka Conakry Guinea
- 1 Department of Dermatology-STD in the University Hospital of Donka, Conakry, Guinea
- 2 Department of Dermatology-STD in the University Hospital of Donka, Conakry, Guinea
- 3 Department of Dermatology-STD in the University Hospital of Donka, Conakry, Guinea
- 4 Department of Intensives Cares, Medico-Surgeon Urgences in the University Hospital of Donka, Conakry, Guinea
- 5 Department of Dermatology-STD in the University Hospital of Donka, Conakry, Guinea
- 6 Department of Tropical Infection Diseases in the University Hospital of Donka, Conakry, Guinea
- 7 Department of Dermatology-STD in the University Hospital of Donka, Conakry, Guinea
- 8 Department of Dermatology-STD in the University Hospital of Donka, Conakry, Guinea
Abstract
Introduction : The psoriasis is one of the inflammatory dermatoses with unknown etiology, with chronic evolution having episodic appearance and disappearance. Its prevalence in HIV patients varied from 2% to 5% in most of the times. Objective of this study was to describe the demographic, clinical and therapeutic characteristics of psoriasis patients infected with HIV. Methods : It is a descriptive retrospective study done from January 2003 to December 2013 based on the information from the hospital card of hospitalized patients and outpatients taken care in the department of Dermatology-STD for psoriasis at the University hospital center in Donka Conakry. We included all the cases of psoriasis associated with HIV infection diagnosed from clinical and paraclinical elements. Results : We recorded 23 (24.73%) cases of psoriasis associated with HIV infection among 93 patients observed for psoriasis in which there are 4 cases of psoriasis vulgaris, 10 cases of erythrodermic psoriasis and 9 cases of arthropathic form among these numbers. We had 7 women and 16 men. The medium age of our patients was 44.5 ± 12 years [ 27 - 62 years ] . The delayed duration time of consultation varied from 30 to more than 180 days. The psoriasis was the circumstance of the discovery of the HIV infection among 55% of cases. The pruritus was the functional sign which is the most frequent in 20 cases among 23 cases and 71.4% of cases were accompanied with pain. Family history was found in 7.10% of cases. Anxiety was the dominant factor cause in 42% and the infection 38%. The cutaneous alteration was noted in all patients; 92.9% of patients had nails alteration and intertrigineous association in 78.6% of cases. The clinical forms found w ere psoriasis vulgaris 4/23 cases, arthropathic psoriasis 9/23 cases, erythrodermic psoriasis 10/23. More than half (13/23) cases of our patients were diagnosed stage III of the classification of WHO. The complicated form s like erythrodermic and arthropathic psoriasis were frequent in patients whose total CD4 < 350 cells/μl about 65%. The most frequently encounte red co-morbidity was tuberculosis (9 cases). The use of traditional therapeutic means was noted in 50% of cases. The local treatment was based on dermocorticoid and keratolylic drugs. The general treatment received by all patients was antiretroviral medication and Methotrexate. Discussion : Our results are of course not representing all the cases of psoriasis in Guinea but it gives us an idea of the importance of HIV and psoriasis association and the influence of immunodepressi on inducted by HIV during the evolution of psoriasis. The demographic, clinical and therapeutic characteri sti cs described in our patients were near those reported by more authors. Conclusion : HIV-associated psoriasis does not appear to be familial. Serious clinical forms occur in highly immunocompromised patients.
- Dubertret, L. (1995) Psoriasis. ISED, Edition du Dome, 265-270.
- Gabla, A., Eti, E., Nebavi, Z., Aka, B., Kanga, J.M., Ouattara, B., et al. (1997) Le rhumatisme psoriasique en milieu hospitalier: A propos de 10 cas. Rhumatologie, 49, 91-94.
- Mahé, A., Bobin, P., Coulibaly, S. and Tounkara, A. (1997) Dermatoses révélatrices de l'infection par le virus de l'immunodéficience humaine au Mali. Annales De Dermatologie Et De Venereologie, 124, 144-150.
- Classification (2009) OMS/2004 in Mémento thérapeutique du VIH /SIDA en Afrique. 2ème édition.
- Leal, L., Ribera, M. and Dauden, E. (2008) Psoriasis and HIV Infection. Actas Dermo-Sifiliográficas, 99, 753-763. https://doi.org/10.1016/S0001-7310(08)74955-X
- Mallon, E. and Bunker, C.B. (2000) HIV-Associated Psoriasis. AIDS Patient Care STDs, 14, 239-246. https://doi.org/10.1089/108729100317696
- Obuch, M.L., Maurer, T.A., Becker, B. and Berger, T.G. (1992) Psoriasis and Human Immunodeficiency Virus Infection. Journal of the American Academy of Dermatology, 27, 667-673. https://doi.org/10.1016/0190-9622(92)70234-7
- Lu, W., Djemadji-Oudjiel, N. and Hiletework, M. (1998) HIV-assoziierte Psoriasis. Klinische und histologische Beobachtungen an 36 Patienten. Hautarzt, 49, 197-202.
- Farber, E.M. and Nall, L. (1998) Epidemiology: Natural History and Genetics. In: Roenigk Jr., H.H. and Maibach, H.I., Eds., Psoriasis, Dekker, New York, 107-115.
- Mebazaa, A., Hawilo, A., Abdelmalek, R., CheikhRouhou, R., Zribi, H. and Trojjet, S, (2011) Psoriasis révélant une infection par le VIH. Revue Tunisienne d’Infectiologie, 5, 36-38.
- Goh, B.K., Chan, R.K.W., Sen, P., Theng, C.T.S., Tan, H.H., Wu, Y.J., et al. (2007) Spectrum of Skin Disorders in Human Immunodeficiency Virus-Infected Patients in Singapore and the Relationship to CD4 Lymphocyte Counts. International Journal of Dermatology, 46, 695-699. https://doi.org/10.1111/j.1365-4632.2007.03164.x
- Ettehadi, P., Greaves, M.W., Wallach, D., Aderka, D. and Camp, R.D. (1994) Elevated Tumor Necrosis Factor-Alpha (TNF-Alpha) Biological Activity in Psoriatic Lesions. Clinical & Experimental Immunology, 96, 146-151. https://doi.org/10.1111/j.1365-2249.1994.tb06244.x
- Mamkin, I., Mamkin, A. and Ramanan, S. (2007) HIV-Associated Psoriasis. The Lancet Infectious Diseases, 7, 496. https://doi.org/10.1016/S1473-3099(07)70161-5